# Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

> **NCT01018745** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 3 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BMS-907351 (XL184)

## Key facts

- **NCT ID:** NCT01018745
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2011-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018745, "Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01018745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*